Literature DB >> 15840738

Correlates of circulating androgens in mid-life women: the study of women's health across the nation.

Nanette Santoro1, Javier Torrens, Sybil Crawford, Jenifer E Allsworth, Joel S Finkelstein, Ellen B Gold, Stan Korenman, William L Lasley, Judith L Luborsky, Dan McConnell, Mary Fran Sowers, Gerson Weiss.   

Abstract

CONTEXT: Androgens influence sexual differentiation and behavior, body composition, and physical functioning in men, but their role in women is less well understood. Because circulating androgens decline with age, the use of androgen supplementation for women to improve health and well-being has been increasing.
OBJECTIVE: The aim of this study was to assess the association between androgens and a variety of end points thought to be affected by androgens.
DESIGN: In a community-based baseline cohort of women aged 42-52 yr from the Study of Women's Health Across the Nation, we measured circulating testosterone (T), dehydroepiandrosterone sulfate, and SHBG, and calculated a free androgen index (FAI) in 2961 women. MAIN OUTCOME MEASURES: Correlations of androgen measures with each other and with body mass index, waist circumference, and waist-hip ratio were computed, and odds ratios (OR) were estimated for the categorical outcomes of functional limitations, functional status, self-reported health, scores indicative of depressed mood, quality of life, sexual desire and arousal, and the presence of the metabolic syndrome.
RESULTS: Androgens, and particularly SHBG, were associated most strongly with body mass index, waist circumference, and waist-hip ratio. SHBG was associated prominently inversely with the metabolic syndrome (OR = 0.32; 95% confidence interval = 0.26-0.39), which was present in 17% of women at baseline. Dehydroepiandrosterone sulfate was associated modestly with functional status and self-reported health. T was associated minimally with increased sexual desire (OR = 1.09; 95% confidence interval = 1.00-1.18). The association of FAI with self-reported health and depressive symptomatology based on the Center for Epidemiologic Studies Depression Scale score was explained more by T than by SHBG, whereas the association of FAI with sexual arousal and metabolic syndrome was due more to SHBG than to T.
CONCLUSIONS: Circulating SHBG and androgens are most strongly associated with physical characteristics and the metabolic syndrome in women in this community-based cohort. Androgens are related weakly to physical functioning and other symptoms to which they commonly are attributed, such as sexual desire, sexual arousal, and well-being.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840738     DOI: 10.1210/jc.2004-2063

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  50 in total

1.  Defects in cortical microarchitecture among African-American women with type 2 diabetes.

Authors:  E W Yu; M S Putman; N Derrico; G Abrishamanian-Garcia; J S Finkelstein; M L Bouxsein
Journal:  Osteoporos Int       Date:  2014-11-15       Impact factor: 4.507

2.  Diabetes and femoral neck strength: findings from the Hip Strength Across the Menopausal Transition Study.

Authors:  Shinya Ishii; Jane A Cauley; Carolyn J Crandall; Preethi Srikanthan; Gail A Greendale; Mei-Hua Huang; Michelle E Danielson; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

3.  Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy.

Authors:  Andrea Salonia; Andrea Gallina; Firas Abdollah; Alberto Briganti; Umberto Capitanio; Nazareno Suardi; Matteo Ferrari; Marco Raber; Renzo Colombo; Massimo Freschi; Patrizio Rigatti; Francesco Montorsi
Journal:  World J Urol       Date:  2011-09-21       Impact factor: 4.226

Review 4.  Anterior pituitary hormone replacement therapy--a clinical review.

Authors:  Christoph J Auernhammer; George Vlotides
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 5.  [Female sexual dysfunction].

Authors:  J B Korda
Journal:  Urologe A       Date:  2008-01       Impact factor: 0.639

Review 6.  Management of obesity in the elderly: too much and too late?

Authors:  R L Kennedy; U Malabu; M Kazi; V Shahsidhar
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

Review 7.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

8.  Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women.

Authors:  A Walther; C Tsao; R Pande; C Kirschbaum; E Field; L Berkman
Journal:  Psychoneuroendocrinology       Date:  2019-07-19       Impact factor: 4.905

9.  Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation.

Authors:  Imke Janssen; Lynda H Powell; Sybil Crawford; Bill Lasley; Kim Sutton-Tyrrell
Journal:  Arch Intern Med       Date:  2008-07-28

10.  Factors related to declining luteal function in women during the menopausal transition.

Authors:  N Santoro; S L Crawford; W L Lasley; J L Luborsky; K A Matthews; D McConnell; J F Randolph; E B Gold; G A Greendale; S G Korenman; L Powell; M F Sowers; G Weiss
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.